CytRx Corp.
(Other OTC/NBB : CYTR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
SAVACassava Sciences, Inc. -4.52%48.580.0%$711.87m
GWPHGW Pharmaceuticals Plc -0.28%214.256.1%$393.29m
HZNPHorizon Therapeutics Plc 0.38%90.915.5%$197.75m
JAZZJazz Pharmaceuticals Plc -1.58%168.042.3%$189.90m
VRXValeant Pharmaceuticals International, Inc. 0.58%31.4614.1%$185.11m
BHCBausch Health Cos., Inc. 0.58%31.460.0%$141.41m
CTLTCatalent, Inc. 1.07%113.452.1%$115.20m
ICLRICON plc -2.04%180.684.2%$96.12m
ARGXargenx SE -2.59%330.680.0%$81.80m
PRGOPerrigo Co. Plc -1.64%40.116.8%$71.31m
TNXPTonix Pharmaceuticals Holding Corp. -2.46%1.190.2%$66.62m
ZYNEZynerba Pharmaceuticals, Inc. 0.79%4.506.0%$58.84m
AMRNAmarin Corp. Plc -3.02%6.741.5%$49.30m
UTHRUnited Therapeutics Corp. -0.96%167.1814.1%$44.01m
PBHPrestige Consumer Healthcare, Inc. 0.12%41.824.0%$40.75m

Company Profile

CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.